MicroRNAs and polycystic kidney disease
We present a new hypothesis for cyst growth involving miRNAs and regulation of PKD gene dosage. We propose that manipulating miRNA function in an attempt to normalize PKD gene dosage represents a novel therapeutic strategy in PKD.
Source: Drug Discovery Today: Disease Models - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Genetics | Polycystic Kidney Disease | Renal Failure | Urology & Nephrology